Dr. Raza A. Jafry, MD

Dr. Jafry practices at John Peter Smith Hospital in Fort Worth, Texas, part of Tarrant County, Texas.

Dr. Jafry's NPI, 1073629986, was assigned on August 22, 2006. Dr. Jafry graduated from Dow University of Health Sciences in 1988. Dr. Jafry holds Texas license P 7130.

Dr. Jafry's primary practice is John Peter Smith Hospital, at 1500 S Main St, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 921-3431.

Dr. Jafry's primary practice is John Peter Smith Hospital in Fort Worth, Texas, part of Tarrant County, Texas. Dr. Jafry is also affiliated with Piedmont Columbus Regional - Midtown. The medical group on file is Acclaim Health. Dmand AI also links Dr. Jafry to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jafry practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Jafry's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Jafry is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Jafry's licenses on file in 4 states: Texas, Massachusetts, Wisconsin and Pennsylvania.

Dmand AI lists pancreatitis and sepsis among the conditions Dr. Jafry treats.

CMS data shows 175 Medicare services from Dr. Jafry across 4 procedure codes in 2024, for 88 Medicare patients. Medicare paid $11,738 for them.

CMS counts 88 Medicare patients who saw Dr. Jafry in 2024. The largest group is under 65, with 40 patients. 75% of them have arthritis, and 75% have high blood pressure. 55% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jafry's median patient age at 58, with 76% women.

In 2024, Dr. Jafry wrote 1,369 Medicare Part D claims for 210 patients. 61% of them were for generic drugs. CMS names the drug for 1,332 of them, across 17 drugs with 11 or more claims each, at $2,880,442 in total drug cost. In 2023, CMS named 1,280 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Jafry for performance year 2024, reported as part of a group. Dr. Jafry accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jafry as offering telehealth.

Dmand AI links Dr. Jafry to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Lupus Erythematosus, Systemic and Connective Tissue Diseases. Open Payments lists research payments to Dr. Jafry that name 1 trial.

CMS Open Payments shows 54 general payments to Dr. Jafry from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Amgen Inc. paid the most, $352. It also lists 7 research payments totaling $1,010 in 2023, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Jafry, most recently CMS Stage 1 EHR in 2014.

Dr. Jafry graduated from Dow University of Health Sciences in 1988.

Dr. Jafry is in network with 21 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.